Healthy Skepticism Library item: 5677
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
Re: the promotion of Periactin (cyproheptadine)
1993 May
Abstract:
The studies supplied to MaLAM by Merck to justify the marketing of cyproheptadine do not support the claim.
Keywords:
*analysis/appetite stimulants and suppressants/cyproheptadine/Periactin/Merck/safety & risk information/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/children/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS